These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17119063)

  • 1. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC).
    Pistorius S; Görgens H; Krüger S; Engel C; Mangold E; Pagenstecher C; Holinski-Feder E; Moeslein G; von Knebel Doeberitz M; Rüschoff J; Karner-Hanusch J; Saeger HD; Schackert HK;
    Cancer Lett; 2006 Sep; 241(1):150-7. PubMed ID: 16337339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
    Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation.
    Felix R; Bodmer W; Fearnhead NS; van der Merwe L; Goldberg P; Ramesar RS
    Mutat Res; 2006 Dec; 602(1-2):175-81. PubMed ID: 17087981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.
    Reeves SG; Mossman D; Meldrum CJ; Kurzawski G; Suchy J; Lubinski J; Scott RJ
    Cancer Lett; 2008 Jun; 265(1):39-44. PubMed ID: 18336997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2006 May; 118(10):2479-84. PubMed ID: 16353134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
    Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
    Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
    Frazier ML; O'Donnell FT; Kong S; Gu X; Campos I; Luthra R; Lynch PM; Amos CI
    Cancer Res; 2001 Feb; 61(4):1269-71. PubMed ID: 11245417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
    Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
    J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
    Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.